ANGO logo

AngioDynamics Stock Price

Symbol: NasdaqGS:ANGOMarket Cap: US$347.8mCategory: Healthcare

ANGO Share Price Performance

US$8.56
1.08 (14.44%)
54.9% undervalued intrinsic discount
US$19.00
Fair Value
US$8.56
1.08 (14.44%)
54.9% undervalued intrinsic discount
US$19.00
Fair Value
Price US$8.56
AnalystConsensusTarget US$19.00

ANGO Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget·Updated
Fair Value US$19.00 54.9% undervalued intrinsic discount

Rising Demand For Minimally Invasive Care Will Expand Med Tech

0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative

Recent ANGO News & Updates

No updates

AngioDynamics, Inc. Key Details

US$292.5m

Revenue

US$134.8m

Cost of Revenue

US$157.7m

Gross Profit

US$191.7m

Other Expenses

-US$34.0m

Earnings

Last Reported Earnings
May 31, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
-0.84
Gross Margin
53.92%
Net Profit Margin
-11.62%
Debt/Equity Ratio
3.4%

AngioDynamics, Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About ANGO

Founded
1988
Employees
675
CEO
James Clemmer
WebsiteView website
www.angiodynamics.com

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company’s thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers’ off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, diagnostic and interventional guidewires, and coaxial micro-introducer kits for use in peripheral diagnostic and interventional procedures. In addition, the company provides abscession drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-access kits offer interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

U.S. Market Performance

  • 7 Days: -2.7%
  • 3 Months: 11.4%
  • 1 Year: 20.5%
  • Year to Date: 5.9%
Over the last 7 days, the market has dropped 2.7%, driven by a pullback of 2.4% in the Information Technology sector. As for the longer term, the market has actually risen by 20% in the last year. As for the next few years, earnings are expected to grow by 15% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading